About Us News & Events Investors Careers
Search
Products Solutions Technologies Disease States Contact Us
Tox STATus

Providing the solutions for molecular diagnostics.

The drive towards personalizing patient care is just beginning and the development of increasingly sophisticated medical research and advanced diagnostic technologies will create improvements in healthcare. Nanogen’s molecular diagnostics and rapid testing technologies are uniquely bridging the gap between early-stage scientific research and actual clinical practice. We are committed to helping the healthcare community realize the benefit of point of care diagnostics and to improving patient care through advances in the diagnosis of disease and the evaluation of particular therapies for individual patients.

transforming medicine … one diagnosis at a time

Latest news More
Nanogen and Thermo Fisher Scientific Partner to Provide Molecular Biology Products to Research Market
DRI Capital Inc. Acquires Royalties from Nanogen Inc. for US $10 Million
Nanogen Enters into Agreement to Restructure its Senior Convertible Notes

Upcoming Events More
May 17 - 20, 2008   National Commision on Correctional Health Care (NCCHC)
May 29 - Jun 4, 2008   American Transplant Congress (ATC)
Jun 1 - 5, 2008   American Society for Microbiology (ASM)